Genipin Attenuates Tau Phosphorylation and Aβ Levels in Cellular Models of Alzheimer's Disease. 2021

Meiting Li, and Nan Cai, and Liang Gu, and Lijun Yao, and Decheng Bi, and Weishan Fang, and Zhijian Lin, and Yan Wu, and Hong Xu, and Hui Li, and Zhangli Hu, and Xu Xu
Shenzhen Key Laboratory of Marine Bioresources and Ecology, Guangdong Provincial Key Laboratory for Plant Epigenetics, College of Life Sciences and Oceanography, Shenzhen University, Shenzhen, 518060, People's Republic of China.

Alzheimer's disease (AD) is a devastating brain disorder characterized by neurofibrillary tangles and amyloid plaques. Inhibiting Tau protein and amyloid-beta (Aβ) production or removing these molecules is considered potential therapeutic strategies for AD. Genipin is an aglycone and is isolated from the extract of Gardenia jasminoides Ellis fruit. In this study, the effect and molecular mechanisms of genipin on the inhibition of Tau aggregation and Aβ generation were investigated. The results showed that genipin bound to Tau and protected against heparin-induced Tau fibril formation. Moreover, genipin suppressed Tau phosphorylation probably by downregulating the expression of CDK5 and GSK-3β, and activated mTOR-dependent autophagy via the SIRT1/LKB1/AMPK signaling pathway in Tau-overexpressing cells. In addition, genipin decreased Aβ production by inhibiting BACE1 expression through the PERK/eIF2α signaling pathway in N2a/SweAPP cells. These data indicated that genipin could effectively lead to a significant reduction of phosphorylated Tau level and Aβ generation in vitro, suggesting that genipin might be developed into an effective therapeutic complement or a potential nutraceutical for preventing AD.

UI MeSH Term Description Entries
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000544 Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) Acute Confusional Senile Dementia,Alzheimer's Diseases,Dementia, Alzheimer Type,Dementia, Senile,Presenile Alzheimer Dementia,Senile Dementia, Alzheimer Type,Alzheimer Dementia,Alzheimer Disease, Early Onset,Alzheimer Disease, Late Onset,Alzheimer Sclerosis,Alzheimer Syndrome,Alzheimer Type Senile Dementia,Alzheimer's Disease,Alzheimer's Disease, Focal Onset,Alzheimer-Type Dementia (ATD),Dementia, Presenile,Dementia, Primary Senile Degenerative,Early Onset Alzheimer Disease,Familial Alzheimer Disease (FAD),Focal Onset Alzheimer's Disease,Late Onset Alzheimer Disease,Primary Senile Degenerative Dementia,Senile Dementia, Acute Confusional,Alzheimer Dementias,Alzheimer Disease, Familial (FAD),Alzheimer Diseases,Alzheimer Type Dementia,Alzheimer Type Dementia (ATD),Alzheimers Diseases,Dementia, Alzheimer,Dementia, Alzheimer-Type (ATD),Familial Alzheimer Diseases (FAD),Presenile Dementia,Sclerosis, Alzheimer,Senile Dementia
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016229 Amyloid beta-Peptides Peptides generated from AMYLOID BETA-PEPTIDES PRECURSOR. An amyloid fibrillar form of these peptides is the major component of amyloid plaques found in individuals with Alzheimer's disease and in aged individuals with trisomy 21 (DOWN SYNDROME). The peptide is found predominantly in the nervous system, but there have been reports of its presence in non-neural tissue. Alzheimer beta-Protein,Amyloid Protein A4,Amyloid beta-Peptide,Amyloid beta-Protein,beta Amyloid,beta-Amyloid Protein,Alzheimer's ABP,Alzheimer's Amyloid Fibril Protein,Amyloid AD-AP,Amyloid Fibril Protein, Alzheimer's,Amyloid beta-Proteins,ABP, Alzheimer's,AD-AP, Amyloid,Alzheimer ABP,Alzheimer beta Protein,Alzheimers ABP,Amyloid AD AP,Amyloid beta Peptide,Amyloid beta Peptides,Amyloid beta Protein,Amyloid beta Proteins,Amyloid, beta,Protein A4, Amyloid,Protein, beta-Amyloid,beta Amyloid Protein,beta-Peptide, Amyloid,beta-Peptides, Amyloid,beta-Protein, Alzheimer,beta-Protein, Amyloid,beta-Proteins, Amyloid
D016875 tau Proteins Microtubule-associated proteins that are mainly expressed in neurons. Tau proteins constitute several isoforms and play an important role in the assembly of tubulin monomers into microtubules and in maintaining the cytoskeleton and axonal transport. Aggregation of specific sets of tau proteins in filamentous inclusions is the common feature of intraneuronal and glial fibrillar lesions (NEUROFIBRILLARY TANGLES; NEUROPIL THREADS) in numerous neurodegenerative disorders (ALZHEIMER DISEASE; TAUOPATHIES). tau Protein,Protein, tau,Proteins, tau
D017434 Protein Structure, Tertiary The level of protein structure in which combinations of secondary protein structures (ALPHA HELICES; BETA SHEETS; loop regions, and AMINO ACID MOTIFS) pack together to form folded shapes. Disulfide bridges between cysteines in two different parts of the polypeptide chain along with other interactions between the chains play a role in the formation and stabilization of tertiary structure. Tertiary Protein Structure,Protein Structures, Tertiary,Tertiary Protein Structures
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Meiting Li, and Nan Cai, and Liang Gu, and Lijun Yao, and Decheng Bi, and Weishan Fang, and Zhijian Lin, and Yan Wu, and Hong Xu, and Hui Li, and Zhangli Hu, and Xu Xu
January 2017, Frontiers in neurology,
Meiting Li, and Nan Cai, and Liang Gu, and Lijun Yao, and Decheng Bi, and Weishan Fang, and Zhijian Lin, and Yan Wu, and Hong Xu, and Hui Li, and Zhangli Hu, and Xu Xu
October 2015, European journal of pharmacology,
Meiting Li, and Nan Cai, and Liang Gu, and Lijun Yao, and Decheng Bi, and Weishan Fang, and Zhijian Lin, and Yan Wu, and Hong Xu, and Hui Li, and Zhangli Hu, and Xu Xu
October 2012, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics,
Meiting Li, and Nan Cai, and Liang Gu, and Lijun Yao, and Decheng Bi, and Weishan Fang, and Zhijian Lin, and Yan Wu, and Hong Xu, and Hui Li, and Zhangli Hu, and Xu Xu
January 2023, Methods in molecular biology (Clifton, N.J.),
Meiting Li, and Nan Cai, and Liang Gu, and Lijun Yao, and Decheng Bi, and Weishan Fang, and Zhijian Lin, and Yan Wu, and Hong Xu, and Hui Li, and Zhangli Hu, and Xu Xu
July 2019, Journal of natural products,
Meiting Li, and Nan Cai, and Liang Gu, and Lijun Yao, and Decheng Bi, and Weishan Fang, and Zhijian Lin, and Yan Wu, and Hong Xu, and Hui Li, and Zhangli Hu, and Xu Xu
January 2004, Gaceta medica de Mexico,
Meiting Li, and Nan Cai, and Liang Gu, and Lijun Yao, and Decheng Bi, and Weishan Fang, and Zhijian Lin, and Yan Wu, and Hong Xu, and Hui Li, and Zhangli Hu, and Xu Xu
October 2020, Neurobiology of disease,
Meiting Li, and Nan Cai, and Liang Gu, and Lijun Yao, and Decheng Bi, and Weishan Fang, and Zhijian Lin, and Yan Wu, and Hong Xu, and Hui Li, and Zhangli Hu, and Xu Xu
March 2021, Aging cell,
Meiting Li, and Nan Cai, and Liang Gu, and Lijun Yao, and Decheng Bi, and Weishan Fang, and Zhijian Lin, and Yan Wu, and Hong Xu, and Hui Li, and Zhangli Hu, and Xu Xu
December 2016, Neurobiology of aging,
Meiting Li, and Nan Cai, and Liang Gu, and Lijun Yao, and Decheng Bi, and Weishan Fang, and Zhijian Lin, and Yan Wu, and Hong Xu, and Hui Li, and Zhangli Hu, and Xu Xu
March 2016, Chemical biology & drug design,
Copied contents to your clipboard!